Organization | Phase One Foundation

Phase One Foundation Report issue

Academic/Hospital Phase 1

Founded: Los Angeles CA United States (1999)

Organization Overview

First Clinical Trial

2013

NCT01811992

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Phase One Foundation

Active Ingredients

Drugs in Phase 1 Trials (7)

ad-hcmv-flt3l (1 trial)

ad-hcmv-tk (1 trial)

autologous dendritic cells loaded with autologous tumor lysate (1 trial)

mocetinostat (1 trial)

pembrolizumab (keytruda) (1 trial)

poly-iclc (1 trial)

vinorelbine (navelbine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Glioblastoma (Phase 1)

Glioma (Phase 1)

Rhabdomyosarcoma (Phase 1)

Overview

Highest Phase: Phase 1
# of Trials: 3
# of Trial APIs: 7